{
  "docId": "019de070-c9e1-7644-aac7-afa340d8795d",
  "docSlug": "fc9db8b68eed863ebdeb09cbc0c7e18a",
  "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 86 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 76,
  "pageCount": 86,
  "prevPage": 75,
  "nextPage": 77,
  "slideType": "key_messages",
  "function": "quantify_opportunity",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "Slide uses a split-layout comparing two distinct product strategies (COPD vs Asthma).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-c9e1-7644-aac7-afa340d8795d/76",
  "deckHref": "/decks/019de070-c9e1-7644-aac7-afa340d8795d",
  "deckJsonHref": "/decks/019de070-c9e1-7644-aac7-afa340d8795d.json",
  "deckAnchorHref": "/decks/019de070-c9e1-7644-aac7-afa340d8795d#slide-76",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.28,
        "x": 0.68,
        "y": 0.78
      },
      "kind": "callout",
      "text": "Rescue medicines valued at $2.5bn",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "867ed13d-2b25-410a-8fb8-76017c630c48",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.1,
        "x": 0.48,
        "y": 0.55
      },
      "kind": "chart",
      "text": "Breztri vs Competitor volume",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "082adb0f-536b-4271-bf84-78c76c7405ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.22,
        "x": 0.08,
        "y": 0.32
      },
      "kind": "chart",
      "text": "COPD patient segments",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21a9f5dc-4cca-42bf-a8a7-92e7deaa190e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.18,
        "x": 0.25,
        "y": 0.45
      },
      "kind": "chart",
      "text": "Launch aligned TRx volume",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e930852d-34dc-4590-8ae2-4f2eb174247c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.68,
        "y": 0.35
      },
      "kind": "list",
      "text": "Replace traditional SABA rescue approach with 'as needed' ICS/SABA to treat underlying inflammation. Phase III results in H2 2021.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cff399fb-fb21-43ee-afcf-dc4e1a50fd4d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.68,
        "y": 0.65
      },
      "kind": "metric",
      "text": "71m rescue inhalers used in the US per year",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a7a851c-1eb8-4681-90e7-3e67b2669cb3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.28,
        "x": 0.68,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "Sources: NIH, NAEPP report: 2020 focused updates to the asthma management guidelines [online]. IQVIA, MAT sales 2020, Rescue defined as SABA only. 1. Short-acting beta agonist.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c53769d5-7674-4a31-add0-542b97beee18",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.68,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Next-generation medicines for mild and moderate disease",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b9a8f137-59de-4bab-b520-b47c6c4c6536",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.68,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Breztri and PT027: strength in inhaled medicines",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a328dd7c-1d1c-49d5-b085-1fc7bd8a1c5c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}